Lynn Seely - President and CEO, Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lynn Seely since 12/22/2023

Holdings reported by Lynn Seely for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 200K $456K $2.28 Feb 9, 2024 Direct
Stock Option (right to buy) 0 Nov 16, 2023 Direct Common Stock

Transactions reported by Lynn Seely for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.